Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

COVID-19 CDC Publications Database
COVID-10 GPH

Last data update: Dec 04, 2023 . (Total: 1932 publications since 2020)
(Author names in bold with hyperlink are CDC authors)
Filtered By:
Order By:
Records 1-6 (of 6 Records)
Query Trace: Miller JD[original query]
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
Link-Gelles R , Ciesla AA , Roper LE , Scobie HM , Ali AR , Miller JD , Wiegand RE , Accorsi EK , Verani JR , Shang N , Derado G , Britton A , Smith ZR , Fleming-Dutra KE .
MMWR Morb Mortal Wkly Rep 2023 72 (5) 119-124
type type type type type
Preliminary estimates of effectiveness of monovalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection among children aged 3-5 years - increasing community access to testing program, United States, July 2022-February 2023
Fleming-Dutra KE , Ciesla AA , Roper LE , Smith ZR , Miller JD , Accorsi EK , Verani JR , Shang N , Derado G , Wiegand RE , Pilishvili T , Britton A , Link-Gelles R .
MMWR Morb Mortal Wkly Rep 2023 72 (7) 177-182
type type type type
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
Link-Gelles R , Ciesla AA , Fleming-Dutra KE , Smith ZR , Britton A , Wiegand RE , Miller JD , Accorsi EK , Schrag SJ , Verani JR , Shang N , Derado G , Pilishvili T .
MMWR Morb Mortal Wkly Rep 2022 71 (48) 1526-1530
type type type type
The Impact of Community-Based Testing Sites and Gift Incentives on COVID-19 Testing Uptake in Maryland, April 29 - May 9, 2021.
Turbyfill C , Thomas I , Agravat N , Prasher JM , Nett RJ , Stevens M , Ricaldi JN , Dunams TM , Brickhouse-Frazier L , Carter MD , Gebru Y , King A , May CS , Miller JD , Oguh C , Pullman A , Roman K , Rose C , Scherr R , Sidibe T , Soelaeman R , Weinstein J , Wilson T , Tran CH .
Am J Health Promot 2022 37 (2) 8901171221119796
type type type type type
Community-Based Testing Sites for SARS-CoV-2 - United States, March 2020-November 2021.
Miller MF , Shi M , Motsinger-Reif A , Weinberg CR , Miller JD , Nichols E .
MMWR Morb Mortal Wkly Rep 2021 70 (49) 1706-1711
type type type type type
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.
Bastard P , Michailidis E , Hoffmann HH , Chbihi M , LeVoyer T , Rosain J , Philippot Q , Seeleuthner Y , Gervais A , Materna M , deOliveira PMN , Maia MLS , DinisAnoBom AP , Azamor T , ArajodaConceio D , Goudouris E , Homma A , Slesak G , Schfer J , Pulendran B , Miller JD , Huits R , Yang R , Rosen LB , Bizien L , Lorenzo L , Chrabieh M , Erazo LV , Rozenberg F , Jeljeli MM , Bziat V , Holland SM , Cobat A , Notarangelo LD , Su HC , Ahmed R , Puel A , Zhang SY , Abel L , Seligman SJ , Zhang Q , MacDonald MR , Jouanguy E , Rice CM , Casanova JL .
J Exp Med 2021 218 (4)
type type type type type
TOP